Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion type Assertion NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_head.
- NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion description "[In this pilot study, we utilized a retroviral vector expressing methylguanine DNA methyltransferase (MGMT) to transduce hematopoietic progenitors, which were subsequently used in the setting of alkylator therapy (procarbazine, CCNU, vincristine (PCV)) for poor prognosis brain tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_provenance.
- NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion evidence source_evidence_literature NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_provenance.
- NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion SIO_000772 16645619 NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_provenance.
- NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion wasDerivedFrom befree-20150227 NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_provenance.
- NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_assertion wasGeneratedBy ECO_0000203 NP840439.RAFxUg-eII2cj_0Fw7xoqVGYSBdKCcR2SsG08MYZIfyFU130_provenance.